Edgar Fenzl is a physician with a doctorate in clinical pharmacology. He has over 35 years experience in pharmaceutical medicine. He has worked in a number of pharmaceutical companies and clinical research organizations, where he has held appointments with increasing responsibilities as chief physician, head of clinical research units and managing director.
Dr. Fenzl has overseen a large number of in-house, national and international clinical studies. He has supervised and managed phase I to IV clinical studies in pharmacokinetics, in a broad range of medical indications, as well as studies for OTC products; he is widely published in these. As head of clinical research for a number of companies he has supervised project leaders and medical advisors, and acted as the Sponsors responsible medical officer for drug safety and regulatory issues. He has extensive experience in company organization and management, including company restructuring ("reengineering").
His current focus is on providing personnally service as an QP for Pharmacovigilance for clients and consulting on drug development and regulatory topics. He is Managing Director of FGK Clinical Research GmbH, FGK Clinical Research Kft. and FGK Representative Service GmbH and serves as a Director at FGK Clinical Research Limited.
+ 49 (0) 89 893 119-22
+ 49 (0) 172-673 8556
Martin Krauss has over 20 years experience in the area of clinical and epidemiological studies, including work in biometry, statistical consulting, SAS programming, clinical research, phase II - IV trials, post marketing surveillance, quality assurance, structuring and optimization of processes, project management in national and international studies, medical device investigations, speaker in seminars in biometry, GCP and medical devices. He has over 15 years experience as managing director, including responsibility for human resources, controlling, accounting, clinical operations and business development. In November 2017 he has been elected as new President of the German CRO association BVMA.
+ 49 (0) 89 893 119-25
+ 49 (0) 173-581 4683